Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data

BACKGROUND: An affordable, highly immunogenic Neisseria meningitidis serogroup A meningococcal conjugate vaccine (PsA–TT) was licensed for use in sub-Saharan Africa in 2009. In 2010, Burkina Faso became the first country to implement a national prevention campaign, vaccinating 11.4 million people ag...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Lancet Infect Dis
Egile Nagusiak: Novak, Ryan T, Kambou, Jean Ludovic, Diomandé, Fabien V K, Tarbangdo, Tiga F, Ouédraogo-Traoré, Rasmata, Sangaré, Lassana, Lingani, Clement, Martin, Stacey W, Hatcher, Cynthia, Mayer, Leonard W, LaForce, F Marc, Avokey, Fenella, Djingarey, Mamoudou H, Messonnier, Nancy E, Tiendrébéogo, Sylvestre R, Clark, Thomas A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4831863/
https://ncbi.nlm.nih.gov/pubmed/22818241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(12)70168-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak